Nadim MK - Search Results

1

Acute Kidney Injury in Patients with Cirrhosis.

Nadim MK, Garcia-Tsao G. Nadim MK, et al. N Engl J Med. 2023 Feb 23;388(8):733-745. doi: 10.1056/NEJMra2215289. N Engl J Med. 2023. PMID: 36812435 Review. No abstract available.

2

Living donor liver transplantation for hepatorenal syndrome: to do or not to do? That is the question.

Nadim MK, Sung RS. Nadim MK, et al. Liver Transpl. 2012 Oct;18(10):1138-9. doi: 10.1002/lt.23498. Liver Transpl. 2012. PMID: 22740330 Free article. No abstract available.

3

Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.

Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V. Wong F, et al. Among authors: nadim mk. Gut. 2011 May;60(5):702-9. doi: 10.1136/gut.2010.236133. Epub 2011 Feb 15. Gut. 2011. PMID: 21325171

4

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Bisognano JD, et al. Among authors: nadim mk. J Am Coll Cardiol. 2011 Aug 9;58(7):765-73. doi: 10.1016/j.jacc.2011.06.008. J Am Coll Cardiol. 2011. PMID: 21816315 Free article. Clinical Trial.

5

Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.

Mackenzie HS, Ziai F, Omer SA, Nadim MK, Taal MW. Mackenzie HS, et al. Among authors: nadim mk. J Am Soc Nephrol. 1999 Apr;10 Suppl 12:S283-6. J Am Soc Nephrol. 1999. PMID: 10201884 Review.

6

Blood-management programs: a clinical and administrative model with program implementation strategies.

Tokin C, Almeda J, Jain S, Kim J, Henderson R, Nadim M, Sher L, Selby RR. Tokin C, et al. Perm J. 2009 Winter;13(1):18-28. doi: 10.7812/TPP/08-029. Perm J. 2009. PMID: 21373242 Free PMC article. No abstract available.

7

Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations.

Francoz C, Nadim MK, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F. Francoz C, et al. Among authors: nadim mk. Hepatology. 2014 Apr;59(4):1514-21. doi: 10.1002/hep.26704. Epub 2014 Mar 3. Hepatology. 2014. PMID: 24037821

8

Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Bakris GL, et al. Among authors: nadim mk. J Am Soc Hypertens. 2012 Mar-Apr;6(2):152-8. doi: 10.1016/j.jash.2012.01.003. Epub 2012 Feb 15. J Am Soc Hypertens. 2012. PMID: 22341199 Clinical Trial.

9

Medical management of hepatorenal syndrome.

Davenport A, Ahmad J, Al-Khafaji A, Kellum JA, Genyk YS, Nadim MK. Davenport A, et al. Among authors: nadim mk. Nephrol Dial Transplant. 2012 Jan;27(1):34-41. doi: 10.1093/ndt/gfr736. Nephrol Dial Transplant. 2012. PMID: 22287700 Review.

10

Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression.

Taal MW, Omer SA, Nadim MK, Mackenzie HS. Taal MW, et al. Among authors: nadim mk. Curr Opin Nephrol Hypertens. 2000 Jul;9(4):323-31. doi: 10.1097/00041552-200007000-00001. Curr Opin Nephrol Hypertens. 2000. PMID: 10926167 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page